Home › NCT05288803

Improving Rehabilitation for Veterans After Total Knee Arthroplasty Using Individualized Recovery Trajectories

Who can join

Ages 40 to 90 · All sexes

Inclusion Criteria:

-Veterans who have undergone total knee arthroplasty who present for outpatient rehabilitation treatment at the participating clinics within three weeks of surgery.

Exclusion Criteria:

* postoperative rehabilitation treatment received in the home health or skilled nursing
* age \< 40 or \>90

About the study

This study will examine the impact of a new clinical decision support tool for rehabilitation after total knee arthroplasty (TKA). Typically, TKA rehabilitation is generic with most patients receiving the same dosage and contents of rehabilitation despite notable diversity among patients who undergo TKA. The investigators clinical support decision tool is designed to help physical therapists tailor rehabilitation treatments and dosages to the individual needs, goals, and preferences of Veterans recovering from TKA. This study has the potential to improve Veterans' functional recovery after TKA, while simultaneously reducing the average number of physical therapy visits Veterans attend after surgery by tailoring rehabilitation dosage based upon need. This will ensure the Veterans Health Administration (VHA) has the resources and capacity to provide adequate rehabilitation to every Veteran seeking TKA in the VHA system. Additionally, if successful, this clinical decision support tool could be used to improve outcomes and access for additional patient populations in the future.

What is being tested

• Clinical decision support tool (CDS tool) (other)

Sponsor: VA Office of Research and Development · Participants: 200 · Started: Apr 1, 2022

Contact the study team

• Jennifer E Stevens-Lapsley, PhD · Phone: (303) 949-9304
• Amy L Peters · Phone: (720) 261-9774

Official record on ClinicalTrials.gov — NCT05288803

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.